About us
Evolving medicines, Empowering lives
We are leaders in value-added medicines, developing established molecules into treatment options that healthcare professionals can use to improve the lives and outcomes of patients.
Our dedicated team carries out meticulous research and data analysis to identify and understand areas where we can transform existing molecules into affordable innovations. By actively listening to healthcare professionals and patients, we gain a deep understanding of unmet clinical needs and unseen patient journeys so that we can bring products to market that are truly needed.
Our values
We are allies
Patients are our priority. By understanding the challenges of unseen and forgotten patient groups, we give patients a choice to continue their treatment.
We step beyond
Rethinking the conventional, we relentlessly pursue creative solutions that push the limits of what was once thought possible.
We are smarter
We make a bigger impact by elevating product value for practitioners and for patients.
We are tenacious
We make a bigger impact by elevating product value for practitioners and for patients.
Our four key pillars
At Colonis, everything we do is centred around four key pillars:
Patient centricity
Patients remain at the centre of everything we do. Our commitment extends beyond traditional generic product licensing and commercialisation and focuses on fully understanding the unmet clinical needs, including patients’ unseen journeys, aspirations, and the challenges they face. By actively listening to clinicians, clinical pharmacists, prescribers, patients and professional groups, we can develop solutions that directly address their individual needs and preferences.
Innovation and research
By pushing the boundaries of evolving medicines, we seek to unlock new possibilities. We actively listen to healthcare professionals and patients to gain a deep understanding of unmet clinical needs and unseen patient journeys. This means that we identify the value in medicines both qualitatively and quantitatively to accelerate opportunities to deliver innovative treatment options to patients.
Product development
We are dedicated to continuously advancing our product portfolio. Our commitment to rigorous and efficient product development processes, which consistently meet needs for unique requirements, enables us to bring value-added medicines to market. Applying robust regulatory compliance, and conducting ongoing monitoring, we deliver high-quality value-added medicines.
Collaboration and partnerships
We believe that achieving our vision requires collaboration and strategic partnerships to develop our portfolio so that we can enable patients and healthcare professionals access to medicines that meet unmet clinical needs. We actively seek partnerships that align with our values and enable us to amplify our impact, expand access to our portfolio of products, and maximise patient outcomes across Europe.
